
Cisplat 10mg Injection
Salt Composition: Cisplatin
Expiry Date: 01/2028
Inclusive of all taxes
1 injection
About The Product
Ovarian Cancer
Cisplat 10mg injection is a chemotherapy-based anticancer medicine. It is prescribed to treat certain types of cancer, including Ovarian cancer, Cervical cancer, Testicular cancer, Lung cancer, Head & neck cancers, and Bladder cancer. The generic name of this medication is Cisplatin. It is an alkylating agent that functions by adding alkyl groups to the DNA strands, causing them to form fragments. This is a prescription-based medication that should be injected by a doctor or an experienced nurse only.
Side Effects
- Cisplat 10mg Injection may cause some side effects that vary from one patient to another.
- Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
- Common side effects include: Nausea Hair loss Vision complications Vomiting Swelling of hands and arms Seizures Blood in vomit Increased bleeding Unusual bruises Chest pain Muscle cramps Tingling of hands and feet Dark coloration of urine Dry skin Diarrhea Dehydration Contact your healthcare provider if you face any unusual or persistent side effects.
How To Use
- Cisplat 10mg Injection is given by a doctor or trained nurse under strict medical supervision.
- It is not self-administerable.
- The dosage and duration of the treatment are determined by the doctor based on the stage & type of cancer and the patient's health condition.
Safety Advice
Missed Doses
It is advisable to avoid missing any dose of Cisplat injection however if you miss a dose consult your doctor immediately.
FAQs
Cisplat 10mg Injection is an anticancer medicine used to treat certain types of cancer, including Ovarian cancer, Cervical cancer, Testicular cancer, Lung cancer, Head and neck cancers, and Bladder cancer.
Reference
1. Shikanov, A., Shikanov, S., Vaisman, B., Golenser, J., & Domb, A.
J. (2011).
Cisplatin tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant. Chemotherapy research and practice, 2011(1), 175054.
2. Mattheolabakis, G., Taoufik, E., Haralambous, S., Roberts, M.
L., & Avgoustakis, K. (2009).
In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics, 71(2), 190-195.
3. Tamura, T., Fujita, F., Tanimoto, M., Koike, M., Suzuki, A., Fujita, M., ... & Yoshino, H.
(2002). Anti-tumor effect of intraperitoneal administration of cisplatin-loaded microspheres to human tumor xenografted nude mice.
Journal of controlled release, 80(1-3), 295-307. 4.
Dhar, S., Kolishetti, N., Lippard, S. J., & Farokhzad, O.
C. (2011).
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proceedings of the National Academy of Sciences, 108(5), 1850-1855.
5. Johnsson, A., Olsson, C., Nygren, O., Nilsson, M., Seiving, B., & Cavallin-Stahl, E.
(1995). Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.
Cancer chemotherapy and pharmacology, 37(1), 23-31.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75)
